Suvretta Capital Management, LLC Xenon Pharmaceuticals Inc. Transaction History

Suvretta Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $17.6 Million - $24.3 Million	-692,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $7.28 Million - $16.5 Million	-466,961 Reduced 40.29%	692,000 $21.6 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $8.39 Million - $11 Million	564,850 Added 95.07%	1,158,961 $17.7 Million
Q2 2021 Aug 16, 2021	BUY	$16.81 - $20.0 $2.59 Million - $3.08 Million	154,047 Added 35.01%	594,111 $11.1 Million
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $6.01 Million - $9.38 Million	440,064 New	440,064 $7.88 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.